Our Partners
We selectively partner our programs in order to accelerate timelines and better align resources.
![Theravance Viatris lOGO](https://www.theravance.com/wp-content/uploads/2023/07/US_Viatris_Logo_Horiz_RGB_12.2020.1.png)
Theravance Biopharma has developed YUPELRI® (revefenacin) inhalation solution, under a strategic collaboration with Viatris. Viatris and Theravance Biopharma co-commercialize the product in the United States.
REV-2021-0087
See our latest SEC filings for further details on our partnerships.